• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes.

作者信息

Kulkarni Mrinalini, Reaven Peter D

机构信息

Department of Medicine (CS/111E), Carl T. Hayden VAMC, 650 E. Indian School Road, Phoenix, AZ 85012-1892, USA.

出版信息

Curr Diab Rep. 2002 Jun;2(3):269-73. doi: 10.1007/s11892-002-0094-2.

DOI:10.1007/s11892-002-0094-2
PMID:12643184
Abstract
摘要

相似文献

1
Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes.
Curr Diab Rep. 2002 Jun;2(3):269-73. doi: 10.1007/s11892-002-0094-2.
2
Lipids: new guidelines, intensive treatment, and future directions.脂质：新指南、强化治疗及未来方向。
Tex Heart Inst J. 2006;33(2):180-3.
3
Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.糖尿病患者降低低密度脂蛋白胆固醇所需的大规模随机证据：医学研究委员会/英国心脏基金会心脏保护研究及其他主要试验
Heart. 2000 Oct;84(4):357-60. doi: 10.1136/heart.84.4.357.
4
Lipid management among coronary artery disease patients with diabetes mellitus or advanced age.糖尿病或老年冠状动脉疾病患者的血脂管理。
Am J Cardiol. 2001 Mar 1;87(5):646-9, A10. doi: 10.1016/s0002-9149(00)01447-8.
5
Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.识别冠心病高危患者：降脂药物治疗试验的启示
QJM. 2000 Sep;93(9):567-74. doi: 10.1093/qjmed/93.9.567.
6
[Variability of the hypolipidemic action of simvastatin and fluvastatin in patients with primary hyperlipoproteinemia].[辛伐他汀和氟伐他汀对原发性高脂蛋白血症患者降脂作用的变异性]
Ter Arkh. 1998;70(12):8-13.
7
Heart protection study: a focus on diabetic patients.心脏保护研究：聚焦糖尿病患者。
Curr Diab Rep. 2004 Jun;4(3):185-6. doi: 10.1007/s11892-004-0021-9.
8
[LDL cholesterol in cardiovascular risk patients should be as low as possible].
MMW Fortschr Med. 2007 Oct 11;149(41):44-5.
9
Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.微粒化非诺贝特：其在血脂异常管理中的药效学特性及临床疗效综述
Drugs. 1997 Oct;54(4):615-33. doi: 10.2165/00003495-199754040-00007.
10
Getting more people on statins.
Am J Cardiol. 2002 Sep 15;90(6):683-5. doi: 10.1016/s0002-9149(02)02590-0.

本文引用的文献

1
Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.抗氧化剂补充剂会阻碍冠状动脉疾病且高密度脂蛋白水平低的患者的高密度脂蛋白对辛伐他汀-烟酸疗法的反应。
Arterioscler Thromb Vasc Biol. 2001 Aug;21(8):1320-6. doi: 10.1161/hq0801.095151.
2
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).国家胆固醇教育计划（NCEP）成人高血胆固醇检测、评估与治疗专家小组第三次报告（成人治疗小组第三次报告）执行摘要
JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486.
3
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
吉非贝齐治疗及血脂水平与主要冠状动脉事件的关系：退伍军人事务部高密度脂蛋白胆固醇干预试验（VA-HIT）：一项随机对照试验。
JAMA. 2001 Mar 28;285(12):1585-91. doi: 10.1001/jama.285.12.1585.
4
Is there a potential therapeutic role for vitamin E or other antioxidants in atherosclerosis?维生素E或其他抗氧化剂在动脉粥样硬化中是否具有潜在的治疗作用？
Curr Opin Lipidol. 2000 Dec;11(6):603-7. doi: 10.1097/00041433-200012000-00006.
5
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.晚期肾病患者心血管疾病抗氧化剂二级预防研究（SPACE）：随机安慰剂对照试验
Lancet. 2000 Oct 7;356(9237):1213-8. doi: 10.1016/s0140-6736(00)02783-5.
6
Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors.2型糖尿病中的心血管疾病：新型心血管危险因素的潜在作用。
Curr Opin Lipidol. 2000 Oct;11(5):519-28. doi: 10.1097/00041433-200010000-00010.
7
Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.糖尿病患者降低低密度脂蛋白胆固醇所需的大规模随机证据：医学研究委员会/英国心脏基金会心脏保护研究及其他主要试验
Heart. 2000 Oct;84(4):357-60. doi: 10.1136/heart.84.4.357.
8
MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience.MRC/BHF冠心病死亡风险增加的广泛患者群体中降低胆固醇治疗及补充抗氧化维生素的心脏保护研究：早期安全性和疗效经验
Eur Heart J. 1999 May;20(10):725-41. doi: 10.1053/euhj.1998.1350.
9
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.洛伐他汀对胆固醇水平正常的男性和女性急性冠脉事件的一级预防：空军/德州冠状动脉粥样硬化预防研究（AFCAPS/TexCAPS）的结果
JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615.
10
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S).斯堪的纳维亚辛伐他汀生存研究（4S）中的脂蛋白变化与主要冠心病事件发生率的降低
Circulation. 1998 Apr 21;97(15):1453-60. doi: 10.1161/01.cir.97.15.1453.